Technical Articles
Genetic Disorder
Can DKK-1 Become a Novel Therapeutic Target for Osteogenesis Imperfecta?
Osteogenesis Imperfecta (OI), also known as brittle bone disease, is a rare genetic connective tissue disorder with an incidence of approximately 1/10,000 to 1/20,000. Patients often present with low bone mass, increased bone fragility, recurrent fractures, and may exhibit extra-skeletal manifestations such as blue sclerae, hearing loss, and dentinogenesis imperfecta.
View details
- Stem Cells
- Osteogenesis Imperfecta
- DKK-1
- Genetic Disorder
- 1












